Vessel-X
Commercial- Indications
- Vertebral Compression Fractures
Company intelligence / Profile preview
Spirit Scientific has commercialized Vessel-X®, a novel bone filling containment system for vertebral compression fractures, and is advancing platelet-derived growth factor treatments in osteoarthritis and sports injuries using its proprietary PLT technology. The company’s products are in use globally, with growing clinical adoption of its minimally invasive surgical techniques. Clinical results highlight reduced cement leakage in spine surgeries and promising outcomes in regenerative medicine applications, though detailed trial data is not publicly available.
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Spirit Scientific.